GGrantIndex
← Leaderboards

Thomas W Buford

University Of Alabama At Birmingham

$9,083,841
Attributed
$15,139,587
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,402,339 · 10

By mechanism

P30$6,262,752 · 1
U01$5,627,457 · 1
R01$5,155,006 · 2
T32$2,061,092 · 1
R21$1,196,729 · 3
R56$575,008 · 1

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Innovation

Research focus

InnovationResponseAgingElderlySignal TransductionCollaborationsExerciseTrainingTissuesPreventUniversitiesDisabilityMethodologyResourcesPhysical ExerciseDesignMetabolismAlabamaFutureChronicPre-ClinicalResearch PersonnelIndexingComplex

Grant awards (47)

Comparative Bioenergetics of Aging$1,161,687
P30 · FY2025 · AG
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine.$504,761
T32 · FY2025 · HD
The Exercise and Physical Activity Collaborative Team (ExPACT): A MoTrPAC Clinical Center$1,100,000
U01 · FY2024 · AR
Comparative Bioenergetics of Aging$892,690
P30 · FY2024 · AG
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine.$435,146
T32 · FY2024 · HD
ANG1-7 as an intervention for Alzheimer's Disease.$224,588
R21 · FY2024 · AG · contact PI
Interconnections among Cognition, Pain, and Physical Function in Aging.$104,859
K02 · FY2024 · AG · contact PI
Comparative Bioenergetics of Aging$63,010
P30 · FY2024 · AG
Comparative Bioenergetics of Aging$36,756
P30 · FY2024 · AG
The Exercise and Physical Activity Collaborative Team (ExPACT): A MoTrPAC Clinical Center$2,054,615
U01 · FY2023 · AR
Comparative Bioenergetics of Aging$892,692
P30 · FY2023 · AG
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine.$402,823
T32 · FY2023 · HD · contact PI
ANG1-7 as an intervention for Alzheimer's Disease.$196,641
R21 · FY2023 · AG · contact PI
Interconnections among Cognition, Pain, and Physical Function in Aging.$104,859
K02 · FY2023 · AG · contact PI
Comparative Bioenergetics of Aging$102,928
P30 · FY2023 · AG
The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical Center$97,842
U01 · FY2023 · AR
The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical Center$2,375,000
U01 · FY2022 · AR
Comparative Bioenergetics of Aging$892,690
P30 · FY2022 · AG
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors$515,517
R01 · FY2022 · AG · contact PI
Comparative Bioenergetics of Aging$371,250
P30 · FY2022 · AG
Interconnections among Cognition, Pain, and Physical Function in Aging.$104,859
K02 · FY2022 · AG · contact PI
Comparative Bioenergetics of Aging$892,691
P30 · FY2021 · AG
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors$562,622
R01 · FY2021 · AG · contact PI
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine$384,022
T32 · FY2021 · HD · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$213,098
R01 · FY2021 · AG · contact PI
Interconnections among Cognition, Pain, and Physical Function in Aging.$104,859
K02 · FY2021 · AG · contact PI
Comparative Bioenergetics of Aging$42,445
P30 · FY2021 · AG
Comparative Bioenergetics of Aging$21,221
P30 · FY2021 · AG
Comparative Bioenergetics of Aging$892,692
P30 · FY2020 · AG
Age-Related Dysbiosis and Physical Resilience$575,008
R56 · FY2020 · AG · contact PI
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors$573,072
R01 · FY2020 · AG · contact PI
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine$334,340
T32 · FY2020 · HD · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2020 · AG · contact PI
Interconnections among Cognition, Pain, and Physical Function in Aging.$104,859
K02 · FY2020 · AG · contact PI
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors$575,585
R01 · FY2019 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2019 · AG · contact PI
ACE2 AS A NOVEL THERAPEUTIC TO PRESERVE PHYSICAL FUNCTION IN LATE LIFE (Supplement 2)$269,979
R01 · FY2019 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$63,500
R01 · FY2019 · AG · contact PI
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors$596,690
R01 · FY2018 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2018 · AG · contact PI
ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors$567,243
R01 · FY2017 · AG · contact PI
ACE2 as a novel therapeutic to preserve physical function in late life$304,425
R01 · FY2017 · AG · contact PI
Resveratrol and exercise to treat functional limitations in late life$184,831
R21 · FY2017 · AG · contact PI
Resveratrol and exercise to treat functional limitations in late life$40,169
R21 · FY2017 · AG · contact PI
Resveratrol and exercise to treat functional limitations in late life$187,500
R21 · FY2016 · AG · contact PI
KAATSU Training to Enhance Physical Function of Older Adults with Osteoarthritis$165,000
R21 · FY2015 · AR · contact PI
KAATSU Training to Enhance Physical Function of Older Adults with Osteoarthritis$198,000
R21 · FY2014 · AR · contact PI